The National Hospital of Tropical Diseases and the Japan International Co-operation Agency (JICA) signed a record of discussions for a cooperation project to set up a bench-to-bedside system for sustainable anti-virus (ARV) and HIV prevention in Vietnam.
ARV medicines given to an HIV patient. (Photo: baomoi.com)
Hanoi (VNA) - The NationalHospital of Tropical Diseases and the Japan International Co-operation Agency(JICA) signed a record of discussions for a cooperation project to set up abench-to-bedside system for sustainable anti-virus (ARV) and HIV prevention inVietnam.
The project will evaluate the effectiveness andsustainability of Vietnam’s HIV treatment system and analyse pre-exposurepreventive activity to reduce new cases.
The project will set up connecting systemsbetween central and local hospitals to monitor HIV treatment, discover newcases and provide early diagnosis of treatment failure and drug resistancemutations.
A system of pre-exposure (PrEP) preventivemonitors will be established to contribute to the HIV/AIDS preventionprogramme. The project plans to start in April next year and last until March2024.
Statistics showed that Vietnam has around250,000 HIV-infected people and nearly 14,000 new infections each year, rankingfourth in the Asia-Pacific region.
Funds for treatment and some tests for HIV/AIDSpatients in central-level hospitals are being provided free of charge throughinternational funding sources.
However, as Vietnam has become a middle-incomecountry, international aid has been reduced.
HIV treatment will be covered by healthinsurance and will be provided at local-level health centres, but many localhealth centres do not have experience with HIV treatment.
Patients often have to pay for their own medicalexpenses, which may affect their adherence to treatment procedures and lead toviral outbreaks and drug resistance.
In terms of preventive work, the Ministry ofHealth has issued a plan of PrEP treatment by ARV medicines for 2018-2020.
The plan will be implemented in Hanoi and someprovinces throughout the country.-VNA
Vietnam has expanded health insurance coverage among HIV patients taking ARV treatment to 83.4 percent at present from 50 percent in 2016, helping ensure that they can maintain long-term treatment.
Community-based organisations participating in a USAID-funded project on HIV/AIDS prevention and control have made great contributions to the work in Vietnam thanks to their new ways of doing.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
ARV medicines given to an HIV patient. (Photo: baomoi.com) 
